Oncology's Data Gold Rush: The Asset Is the Patient Data
In 2025 pharma majors moved from buying AI to building it on someone else's data. Tempus and ConcertAI showed the asset in oncology AI is the patient data.
Read More
How a Venture Partner Drives Fintech Innovation: An Interview with Michele Mattei of Allegory Capital
At Allegory Capital, the venture partner model occupies a central position. Michele Mattei, a fintech professional with a background spanning digital banking, accelerators and angel investing, exemplifies how this hybrid role translates market knowledge into portfolio value.
Read More
Europe’s Big AI Bet: How New Guidelines Will Shape the Future of General-Purpose AI Models
Europe’s Bold Step into AI’s Future Setting Clear Boundaries for AI Innovation...
Read More
Switzerland's top engineering schools, ETH and EPFL, are announcing an open-source LLM
Working with the brightest minds Switzerland has to offer, a new language...
Read More
Why Pharma's AI Playbook Looks Nothing Like Fintech's
AI is generating seismic shifts across regulated industries. While fintech leans on...
Read More